In vitro activity of sanfetrinem (GV104326), a new trinem antimicrobial agent, versus Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis
- 1 September 1996
- journal article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 26 (1) , 39-42
- https://doi.org/10.1016/s0732-8893(96)00173-3
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- In vitro activity of the tricyclic beta-lactam GV104326Antimicrobial Agents and Chemotherapy, 1996
- Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: results of a 30-center national surveillance studyAntimicrobial Agents and Chemotherapy, 1996
- In vitro activity of the tribactam GV104326 against gram-positive, gram-negative, and anaerobic bacteriaAntimicrobial Agents and Chemotherapy, 1994
- Improved medium for antimicrobial susceptibility testing of Haemophilus influenzaeJournal of Clinical Microbiology, 1987